Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study

Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma, Kingshuk Bhattacharjee, Ritu Singh
doi: https://doi.org/10.1101/2021.04.07.21255078

Article usage

Article usage: April 2021 to November 2023

AbstractFullPdf
Apr 2021318185641425
May 20214892129951407
Jun 2021116961615965
Jul 20211938457229
Aug 2021943258203
Sep 2021595114143
Oct 20213497472
Nov 20212828093
Dec 20212466869
Jan 20223384178
Feb 20221123337
Mar 2022773121
Apr 2022732014
May 2022651719
Jun 2022411475
Jul 2022502284
Aug 20224899
Sep 2022603015
Oct 2022692712
Nov 2022251010
Dec 2022341521
Jan 2023381010
Feb 2023331517
Mar 20234495
Apr 2023371611
May 20232278
Jun 2023281410
Jul 20231758
Aug 2023341610
Sep 20233598
Oct 2023921217
Nov 20231461714
Back to top
Posted April 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma, Kingshuk Bhattacharjee, Ritu Singh
medRxiv 2021.04.07.21255078; doi: https://doi.org/10.1101/2021.04.07.21255078
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area